⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8059804 | 0.71 | TSHR (0.32) | — | |
| SCHEMBL17225025 | 0.67 | — | — | |
| SCHEMBL17921762 | 0.65 | — | — | |
| SCHEMBL9150662 | 0.65 | TSHR (0.47) | — | |
| SCHEMBL8143350 | 0.64 | — | — | |
| SCHEMBL2559690 | 0.61 | TSHR (0.41) | — | |
| SCHEMBL6063708 | 0.59 | — | — | |
| SCHEMBL9054546 | 0.59 | TSHR (0.39) | — | |
| SCHEMBL9343649 | 0.57 | TSHR (0.44) | — | |
| SCHEMBL109553 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6815212-B2 | DETECTION OF LIGAND BINDING; OBTAIN SAMPLE, INCUBATE WITH LABEL, SEPARATE BOUND COMPLEXES, REMOVE LABEL, DETECT LABEL BY MASS SPECTROSCOPY | QIAGEN GENOMICS, INC. | 2004-11-09 | — | — | US | disclosed |
| EP-0998577-B1 | CONJUGATES OF TRANSPORTER PEPTIDES AND NUCLEIC ACID ANALOGS, AND THEIR USE | PERSEPTIVE BIOSYSTEMS INC (US) | 2004-10-27 | — | — | EP | disclosed |
| WO-2003080645-A2 | AMPLIFICATION OF NUCLEIC ACID FRAGMENTS USING NICKING AGENTS | KECK GRADUATE INSTITUTE (US) | 2003-10-02 | — | — | WO | disclosed |
| US-20030077595-A1 | Methods and compositions for enhancing sensitivity in the analysis of biological-based assays | QIAGEN GENOMICS, INC. | 2003-04-24 | — | — | US | disclosed |
| EP-1222309-A4 | HUMAN RNASE H AND OLIGONUCLEOTIDE COMPOSITIONS THEREOF | ISIS PHARMACEUTICALS INC (US) | 2002-12-04 | — | — | EP | disclosed |
| EP-1222309-A1 | HUMAN RNASE H AND OLIGONUCLEOTIDE COMPOSITIONS THEREOF | ISIS PHARMACEUTICALS, INC. (US) | 2002-07-17 | — | — | EP | disclosed |
| US-6361940-B1 | IMMOBILIZATION; GENETIC ENGINEERING | QIAGEN GENOMICS, INC. | 2002-03-26 | — | — | US | disclosed |
| WO-2001023618-A2 | COMPOSITIONS AND METHODS FOR REDUCING OLIGONUCLEOTIDE HYBRIDIZATION AND PRIMING SPECIFICITY | QIAGEN GENOMICS, INC. (US) | 2001-04-05 | — | — | WO | disclosed |
| WO-2001023613-A1 | HUMAN RNASE H AND OLIGONUCLEOTIDE COMPOSITIONS THEREOF | ISIS PHARMACEUTICALS, INC. (US) | 2001-04-05 | — | — | WO | disclosed |
| EP-1040352-A1 | SOLID-PHASE TIPS AND USES RELATING THERETO | Qiagen Genomics, Inc. (US) | 2000-10-04 | — | — | EP | disclosed |
| US-6025140-A | NUCLEIC ACID ANALOG CONJUGATED TO A PEPTIDE WITH A SPECIFIC AMINO ACID SEQUENCE BY A LABILE BOND; ANALOG TARGETS A SPECIFIC INTRACELLULAR POLYNUCLEOTIDE FOR ANTISENSE THERAPY | PERSEPTIVE BIOSYSTEMS, INC. (US) | 2000-02-15 | — | — | US | disclosed |
| WO-2000004189-A1 | MODIFIED OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. (US) | 2000-01-27 | — | — | WO | disclosed |
| EP-0850320-B1 | METHODS FOR DETECTING BINDING OF LIGAND PAIR WITH ENHANCED SENSITIVITY | RAPIGENE INC (US) | 1999-12-08 | — | — | EP | disclosed |
| EP-0962464-A2 | Methods and compositions for detecting binding of ligand pair using non-fluorescent label | Rapigene, Inc. (US) | 1999-12-08 | — | — | EP | disclosed |
| EP-0952228-A2 | Compositions and methods for enhancing hybridization specificity | Rapigene, Inc. (US) | 1999-10-27 | — | — | EP | disclosed |
| WO-1999034214-A1 | SOLID-PHASE TIPS AND USES RELATING THERETO | QIAGEN GENOMICS, INC (US) | 1999-07-08 | — | — | WO | disclosed |
| WO-1999005302-A1 | CONJUGATES OF TRANSPORTER PEPTIDES AND NUCLEIC ACID ANALOGS, AND THEIR USE | THE PERKIN-ELMER CORPORATION (US) | 1999-02-04 | — | — | WO | disclosed |
| EP-0850320-A2 | METHODS AND COMPOSITIONS FOR DETECTING BINDING OF LIGAND PAIR USING NON-FLUORESCENT LABEL | DARWIN MOLECULAR CORPORATION (US) | 1998-07-01 | — | — | EP | disclosed |
| WO-1997027327-A2 | METHODS AND COMPOSITIONS FOR DETECTING BINDING OF LIGAND PAIR USING NON-FLUORESCENT LABEL | RAPIGENE, INC. (US) | 1997-07-31 | — | — | WO | disclosed |
| WO-1995026359-A1 | MACROMOLECULAR STRUCTURES FOR BORON NEUTRON-CAPTURE THERAPY | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-10-05 | — | — | WO | disclosed |